Extension Study of Protocol ENB-006-09 - Study of Asfotase Alfa in Children With Hypophosphatasia (HPP)
Study Identifier:
ENB-008-10
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Alexion Pharmaceuticals, Inc.
Study Contact Information:
N/A
Study Complete
Study Details
Medical Condition
- Unmapped
Study Drug
- Biological: Asfotase Alfa
Date
Apr 2010 - Jun 2016
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 5 - 12 Years
Requirements Information
Sex
Female & Male
Age
5 - 12 Years
Study Details
Medical Condition
- Unmapped
Study Drug
- Biological: Asfotase Alfa
Date
Apr 2010 - Jun 2016
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 5 - 12 Years years
Requirements Information
Protocol Summary
This clinical trial studies the long term safety and efficacy of asfotase alfa in children with HPP who completed Study ENB-006-09 (NCT00952484).
Trial Locations
Location
Status
Location
Shriners Hospital for Children
Saint Louis, Missouri, United States, 63110
Status
N/A
Location
Children's Hospital Health Sciences Centre
Winnipeg, Manitoba, Canada, R3A 1S1
Status
N/A